Phnom Penh, Cambodia – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, signed a five year agreement with Bayer HealthCare, a specialist in research, development, manufacturing and marketing of general and specialty medicine, to provide importation, custom clearance, logistics and physical distribution as well as credit and collection services for both Bayer's Pharmaceuticals and Consumer Care Divisions.
DKSH Healthcare has supported Bayer's growth in Cambodia since 2003. The company furthermore provides Market Expansion Services for Bayer's Consumer Care and Pharmaceuticals Divisions in Thailand and China.
"For over a decade DKSH has supported Bayer in our growth in the market here. Our decision to extend our partnership in Cambodia is based on their broad capabilities and expertise in innovative value-added services, their dedication to quality and compliance as well as their deep market and industry knowledge," said Maline Srun, Branch Manager of Bayer (Cambodia) Branch.
"The extension of our partnership with Bayer HealthCare in Cambodia for another five years strengthens our position as preferred Market Expansion Services partner for small and medium sized as well as big multinational pharmaceuticals companies who want to grow their business in Cambodia," commented Nicolas Chabanier, General Manager, Business Unit Healthcare, DKSH Cambodia.
The agreement between DKSH and Bayer HealthCare in Cambodia demonstrates DKSH's ability to roll-out success stories from country to country. The agreement will further strengthen DKSH's market position and gradually contribute to the Group's overall profitability.
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 680 business locations in 35 countries – 660 of them in Asia – and 25,900 specialized staff, DKSH generated net sales of CHF 8.8 billion in 2012.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration and market entry studies as well as importation, customs clearance, marketing and sales to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices.
With 150 business locations in 13 countries and 8,270 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated net sales exceeding CHF 3.7 billion in 2012.
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2012, the Group employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2.0 billion, R&D expenses to €3.0 billion. For more information, go to www.bayer.com